| RS1057520736 |
PALB2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1057520737 |
OPHN1
|
Health Risk |
Pathogenic |
X-linked intellectual disability-cerebellar hypoplasia syndrome, X-linked intellectual disability-cerebellar hypoplasia syndrome |
| RS1057520738 |
IRF6
|
Health Risk |
Pathogenic/Likely pathogenic |
Popliteal pterygium syndrome, Orofacial cleft 6 |
| RS1057520739 |
ARSB
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis type 6, Mucopolysaccharidosis type 6 |
| RS1057520740 |
KMT2D
|
Health Risk |
Pathogenic |
— |
| RS1057520742 |
EDA
|
Health Risk |
Likely pathogenic |
Hypohidrotic X-linked ectodermal dysplasia, Hypohidrotic X-linked ectodermal dysplasia |
| RS1057520743 |
CNTNAP2
|
Health Risk |
Pathogenic |
— |
| RS1057520744 |
TTN
|
Health Risk |
Pathogenic/Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1057520746 |
RPL5
|
Health Risk |
Pathogenic/Likely pathogenic |
Diamond-Blackfan anemia, Diamond-Blackfan anemia |
| RS1057520747 |
RERE
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with or without anomalies of the brain, eye |
| RS1057520749 |
CACNA1A
|
Health Risk |
Pathogenic |
— |
| RS1057520750 |
TP63
|
Health Risk |
Pathogenic |
— |
| RS1057520752 |
PRPF31
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa 11 |
| RS1057520753 |
SCN3A
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 62 |
| RS1057520755 |
PAX6
|
Health Risk |
Pathogenic/Likely pathogenic |
Aniridia 1, Irido-corneo-trabecular dysgenesis |
| RS1057520756 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS1057520757 |
CWF19L1
|
Health Risk |
Pathogenic |
— |
| RS1057520758 |
KANSL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1057520759 |
TSC2
|
Health Risk |
Pathogenic |
— |
| RS1057520761 |
PCDH19
|
Health Risk |
Pathogenic |
— |
| RS1057520762 |
GNRHR
|
Health Risk |
Pathogenic |
— |
| RS1057520764 |
DMD
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Duchenne muscular dystrophy |
| RS1057520765 |
CHM
|
Health Risk |
Pathogenic |
— |
| RS1057520766 |
EYA1
|
Health Risk |
Pathogenic |
— |
| RS1057520767 |
GLMN
|
Health Risk |
Pathogenic |
— |
| RS1057520768 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS1057520769 |
VPS13B
|
Health Risk |
Pathogenic/Likely pathogenic |
Cohen syndrome, Cohen syndrome |
| RS1057520770 |
FLNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Frontometaphyseal dysplasia, Melnick-Needles syndrome |
| RS1057520771 |
FKRP
|
Health Risk |
Pathogenic/Likely pathogenic |
Walker-Warburg congenital muscular dystrophy, Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies) |
| RS1057520772 |
FKRP
|
Health Risk |
Pathogenic |
— |
| RS1057520773 |
KCNQ2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1057520775 |
MED13L
|
Health Risk |
Likely pathogenic |
— |
| RS1057520778 |
GJB1
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth Neuropathy X, Charcot-Marie-Tooth disease X-linked dominant 1 |
| RS1057520779 |
HNF1A
|
Health Risk |
Pathogenic |
Monogenic diabetes, Maturity-onset diabetes of the young type 3 |
| RS1057520780 |
FOXG1
|
Health Risk |
Pathogenic |
FOXG1 disorder, FOXG1-related disorder |
| RS1057520781 |
GK
|
Health Risk |
Pathogenic |
— |
| RS1057520783 |
LMX1B
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1057520784 |
SMARCA2
|
Health Risk |
Pathogenic |
— |
| RS1057520785 |
POLR3B
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypomyelinating leukodystrophy 8 with or without oligodontia and-or hypogonadotropic hypogonadism, Hypomyelinating leukodystrophy 8 with or without oligodontia and-or hypogonadotropic hypogonadism |
| RS1057520786 |
PHYH
|
Health Risk |
Pathogenic |
— |
| RS1057520787 |
TUBB2B
|
Health Risk |
Pathogenic |
— |
| RS1057520788 |
DNMT3A
|
Health Risk |
Conflicting classifications of pathogenicity |
Tatton-Brown-Rahman overgrowth syndrome, Tatton-Brown-Rahman overgrowth syndrome |
| RS1057520790 |
RPGRIP1L
|
Health Risk |
Pathogenic/Likely pathogenic |
Joubert syndrome, Meckel-Gruber syndrome |
| RS1057520791 |
CASR
|
Health Risk |
Pathogenic |
Familial hypocalciuric hypercalcemia 1, Familial hypocalciuric hypercalcemia |
| RS1057520792 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS1057520800 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS1057520802 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1057520803 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS1057520813 |
FBN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, Marfan syndrome |
| RS1057520814 |
MYH7
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS1057520815 |
CYP27B1
|
Health Risk |
Pathogenic |
Vitamin D-dependent rickets, type 1 |
| RS1057520828 |
IL7R
|
Health Risk |
Conflicting classifications of pathogenicity |
Immunodeficiency 104, Immunodeficiency 104 |
| RS1057520831 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1057520837 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS1057520841 |
SPTAN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 5 |
| RS1057520843 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS1057520844 |
SCN2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Complex neurodevelopmental disorder, Developmental and epileptic encephalopathy |
| RS1057520846 |
SCN4A
|
Health Risk |
Pathogenic |
— |
| RS1057520852 |
CHRNB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nocturnal frontal lobe epilepsy, Autosomal dominant nocturnal frontal lobe epilepsy |
| RS1057520858 |
IQSEC2
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 1 |
| RS1057520861 |
LRP2
|
Health Risk |
Likely pathogenic |
— |
| RS1057520867 |
DSG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1057520869 |
STK11
|
Health Risk |
Conflicting classifications of pathogenicity |
Peutz-Jeghers syndrome, Hereditary cancer-predisposing syndrome |
| RS1057520873 |
ASPM
|
Health Risk |
Pathogenic |
Microcephaly 5, primary |
| RS1057520880 |
RAF1
|
Health Risk |
Conflicting classifications of pathogenicity |
RASopathy, Cardiovascular phenotype |
| RS1057520897 |
CRYAB
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1II, Cardiovascular phenotype |
| RS1057520900 |
PTEN
|
Health Risk |
Pathogenic |
PTEN hamartoma tumor syndrome, Hemangioma |
| RS1057520911 |
CHD4
|
Health Risk |
Likely pathogenic |
— |
| RS1057520916 |
CDH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary diffuse gastric adenocarcinoma |
| RS1057520918 |
CACNA1A
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Developmental and epileptic encephalopathy |
| RS1057520957 |
TGFBR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, Loeys-Dietz syndrome 2 |
| RS1057520966 |
BMPR1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Juvenile polyposis syndrome, Hereditary cancer-predisposing syndrome |
| RS1057520977 |
MYBPC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Hypertrophic cardiomyopathy |
| RS1057520982 |
PALB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Fanconi anemia complementation group N |
| RS1057520985 |
PALB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1057520996 |
MBD5
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal dominant 1 |
| RS1057520997 |
POLG
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive sclerosing poliodystrophy, Progressive sclerosing poliodystrophy |
| RS1057521013 |
BSCL2
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS1057521034 |
NTRK1
|
Health Risk |
Likely pathogenic |
Hereditary insensitivity to pain with anhidrosis, Hereditary insensitivity to pain with anhidrosis |
| RS1057521041 |
GATAD2B
|
Health Risk |
Pathogenic/Likely pathogenic |
Severe intellectual disability-poor language-strabismus-grimacing face-long fingers syndrome, Severe intellectual disability-poor language-strabismus-grimacing face-long fingers syndrome |
| RS1057521043 |
PTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Gorlin syndrome, Gorlin syndrome |
| RS1057521044 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS1057521047 |
GLA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fabry disease, Fabry disease |
| RS1057521057 |
SGCB
|
Health Risk |
Conflicting classifications of pathogenicity |
Qualitative or quantitative defects of beta-sarcoglycan, Qualitative or quantitative defects of beta-sarcoglycan |
| RS1057521059 |
BCS1L
|
Health Risk |
Pathogenic/Likely pathogenic |
Leigh syndrome, Mitochondrial complex III deficiency nuclear type 1 |
| RS1057521062 |
IL2RG
|
Health Risk |
Likely pathogenic |
X-linked severe combined immunodeficiency, X-linked severe combined immunodeficiency |
| RS1057521063 |
TUBA1A
|
Health Risk |
Likely pathogenic |
Tubulinopathy, Movement disorder |
| RS1057521064 |
TUBA1A
|
Health Risk |
Pathogenic |
Tubulinopathy, Tubulinopathy |
| RS1057521065 |
SCN4A
|
Health Risk |
Likely pathogenic |
Hyperkalemic periodic paralysis, Hyperkalemic periodic paralysis |
| RS1057521066 |
SLC2A1
|
Health Risk |
Pathogenic |
Epilepsy, idiopathic generalized |
| RS1057521068 |
RUNX2
|
Health Risk |
Pathogenic |
Cleidocranial dysostosis, Metaphyseal dysplasia-maxillary hypoplasia-brachydacty syndrome |
| RS1057521070 |
TCF4
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Pitt-Hopkins syndrome |
| RS1057521071 |
ADSL
|
Health Risk |
Conflicting classifications of pathogenicity |
Adenylosuccinate lyase deficiency, Adenylosuccinate lyase deficiency |
| RS1057521074 |
F8
|
Health Risk |
Pathogenic |
— |
| RS1057521077 |
CHD7
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1057521078 |
CHD7
|
Health Risk |
Likely pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS1057521079 |
SCN1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Generalized epilepsy with febrile seizures plus, type 2 |
| RS1057521080 |
SCN1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1057521083 |
SATB2
|
Health Risk |
Pathogenic/Likely pathogenic |
Chromosome 2q32-q33 deletion syndrome, Inborn genetic diseases |
| RS1057521084 |
EIF2B5
|
Health Risk |
Likely pathogenic |
— |